Publications

Publications | Masters and Phd thesis

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

Publications

In Press | 2019 | ...

In Press

Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.

Ansar M., Paracha S.A., Serretti A., Sarwar M.T., Khan J., Ranza E., Falconnet E., Iwaszkiewicz J., Shah S.F., Qaisar A.A. et al. Human molecular genetics. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_CC3DB25E32E9]

Tumor Landscapes: β-Catenin Drives Immune Desertification.

Dangaj D., Barras D., Coukos G. Clinical cancer research. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_7529A1E77088]

Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.

Digklia A., Duran R., Homicsko K., Kandalaft L.E., Hocquelet A., Orcurto A., Coukos G., Denys A. Cardiovascular and interventional radiology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_13E5E5B29D1D]

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.

Lan Q., Peyvandi S., Duffey N., Huang Y.T., Barras D., Held W., Richard F., Delorenzi M., Sotiriou C., Desmedt C. et al. Oncogene. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_94A8CCA9EF90]

2019

Going Beyond the Sequences: TCR Binding Patterns at the Service of Cancer Detection.

Zoete V., Coukos G., 2019/04/01. Cancer research, 79 (7) pp. 1299-1301. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_B6A2460E1FCA]

Publisher Correction: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.

Cheng W.C., Tsui Y.C., Ragusa S., Koelzer V.H., Mina M., Franco F., Läubli H., Tschumi B., Speiser D., Romero P. et al., 2019/04. Nature immunology, 20 (4) pp. 515-516. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_2453C5C48240]

Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.

Niogret C., Miah SMS, Rota G., Fonta N.P., Wang H., Held W., Birchmeier W., Sexl V., Yang W., Vivier E. et al., 2019/03/29. Nature communications, 10 (1) p. 1444. Peer-reviewed.

[URN] [DOI] [WoS] [Pmid] [serval:BIB_1D70F1981844]

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.

Li X., Wenes M., Romero P., Huang S.C., Fendt S.M., Ho P.C., 2019/03/26. Nature reviews. Clinical oncology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_F7C5AE601718]

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.

Westergaard MCW, Andersen R., Chong C., Kjeldsen J.W., Pedersen M., Friese C., Hasselager T., Lajer H., Coukos G., Bassani-Sternberg M. et al., 2019/03/19. British journal of cancer. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_5C827EDF3F51]

Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.

Yu Y.R., Ho P.C., 2019/03/15. Clinical and experimental immunology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_4F2A32ECC9A7]

Circulating CD56<sup>bright</sup> NK cells inversely correlate with survival of melanoma patients.

de Jonge K., Ebering A., Nassiri S., Maby-El Hajjami H., Ouertatani-Sakouhi H., Baumgaertner P., Speiser D.E., 2019/03/14. Scientific reports, 9 (1) p. 4487. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_07410EEFFC5B]

The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.

Vannini N., Campos V., Girotra M., Trachsel V., Rojas-Sutterlin S., Tratwal J., Ragusa S., Stefanidis E., Ryu D., Rainer P.Y. et al., 2019/03/07. Cell stem cell, 24 (3) pp. 405-418.e7. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_9C9755E6E69D]

CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Sciarra A., Monteiro I., Ménétrier-Caux C., Caux C., Gilbert B., Halkic N., La Rosa S., Romero P., Sempoux C., de Leval L., 2019/03. Cancer immunology, immunotherapy, 68 (3) pp. 467-478. Peer-reviewed.

[URN] [DOI] [WoS] [Pmid] [serval:BIB_97044E671671]

Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues

Sciarra A., Monteiro I., Ménétrier-Caux C., Caux C., Gilbert B., Halkic N., La Rosa S., Romero P., Sempoux C., de Leval L., 2019/03. 1.

[DOI] [Pmid] [serval:BIB_7C8F554D8B37]

Differential regulation of RNA polymerase III genes during liver regeneration.

Yeganeh M., Praz V., Carmeli C., Villeneuve D., Rib L., Guex N., Herr W., Delorenzi M., Hernandez N., CycliX consortium, 2019/02/28. Nucleic acids research, 47 (4) pp. 1786-1796. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_014840C5C9E3]

Mutations in the palm domain disrupt modulation of acid-sensing ion channel 1a currents by neuropeptides.

Bargeton B., Iwaszkiewicz J., Bonifacio G., Roy S., Zoete V., Kellenberger S., 2019/02/22. Scientific reports, 9 (1) p. 2599. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_3C115A0AD37A]

50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.

Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_8A5A6B3310C5]

NK cells specifically TCR-dressed to kill cancer cells.

Mensali N., Dillard P., Hebeisen M., Lorenz S., Theodossiou T., Myhre M.R., Fåne A., Gaudernack G., Kvalheim G., Myklebust J.H. et al., 2019/02. EBioMedicine, 40 pp. 106-117. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_C96D4A7DAD14]

Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification.

Mermod M., Bongiovanni M., Petrova T., Goun E., Simon C., Tolstonog G., Monnier Y., 2019/02. Otolaryngology: head and neck surgery, 160 (2) pp. 277-283. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_9BFA9A270953]

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.

Westergaard MCW, Andersen R., Chong C., Kjeldsen J.W., Pedersen M., Friese C., Hasselager T., Lajer H., Coukos G., Bassani-Sternberg M. et al., 2019/02. British journal of cancer, 120 (4) pp. 424-434. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_031BC21D26AB]

Masters thesis

Publications (1)

CANCER IMMUNOTHERAPY WITH VEGFR-3 TARGETED CAR T-CELLS

KIRITSIS K., 2016. 32, Université de Lausanne, Faculté de biologie et médecine, COUKOS G. (dir.).

[URN] [serval:BIB_AD0E970E95CE]

Phd thesis

Publications (3)

Molecular determinants governing CD8+ T cell mediated anti-tumor immunity

Martinez-Usatorre Amaia, 2018/04/27. 117, Université de Lausanne, Faculté de biologie et médecine, Romero Pedro (dir.).

[URN] [serval:BIB_08CEE3B79D75]

Harnessing iNKT and CD8 T cells for Immunotherapy of Cancer

Tschumi Benjamin Olivier, 2018/03/13. 117, Université de Lausanne, Faculté de biologie et médecine, Romero Pedro (dir.).

[URN] [serval:BIB_786BC3B46C6D]

Characterization of local and systemic immune-modulation in melanoma patients

Bordy N., 2015. 204, Université de Lausanne, Faculté de biologie et médecine, Speiser D., Swartz M. (dir.).

[URN] [serval:BIB_9F9512EEBA1F]